Canary Capital has launched a staked Injective (INJ) exchange-traded fund on Nasdaq, giving brokerage investors price exposure plus a path to staking rewards without touching a crypto wallet.
The product joins the firm’s existing Canary XRP ETF and Canary HBAR ETF, and arrives as specialized blockchain networks compete for institutional attention beyond Bitcoin and Ether alone.
INJ was recently trading near $8.23, up roughly 5% on the day and about 10% on the week, even while Bitcoin held above $76,000 amid a broader risk-off slide in tech and crypto.
For Bitcoin investors, the most interesting signal is not the altcoin ticker itself. It is proof that the ETF wrapper Bitcoin pioneered keeps expanding into staking and onchain finance products.
The bigger question now is whether this next wave of crypto ETFs deepens the institutional rails that already support Bitcoin.
What Exactly Did Canary Capital Launch?
Digital asset manager Canary Capital rolled out a Staked INJ ETF designed for traditional brokerage accounts.
CEO Steven McClurg said the fund gives investors access to a blockchain built for finance through a familiar exchange-traded structure, while also enabling potential staking rewards.
“The Canary Staked INJ ETF gives investors access to a blockchain purpose-built for finance through a familiar exchange-traded structure, while also enabling investors to benefit from potential staking rewards,” McClurg said.
He added that allocators are looking past the largest coins toward networks focused on tokenization, trading, and decentralized markets.
Injective Foundation co-founder Eric Chen framed the same idea for mainstream accounts: investors can gain INJ exposure through the brokerage accounts they already use.
“We built Injective to bring financial markets onchain. Canary’s launch connects that mission to a broader base of investors,” Chen said.
We believe that packaging is the real story. Bitcoin proved the spot ETF model works. Products like this show the wrapper can stretch into staking and specialized networks without forcing clients onto exchanges.
Why Injective’s Network Stats Matter to Institutions
According to the firm’s materials, Injective has tokenized more than $1 billion in assets.
As of Oct. 22, the network had processed more than 3.13 billion transactions and permanently burned over 7.27 million INJ, valued at about $58 million, through buyback mechanisms.
Token Terminal data pointed to roughly 257,300 monthly active addresses in October.
More than $25 million in native USDC had been issued on Injective as of October, supporting payments and settlement.
Network upgrades aimed at institutions include Injective Mint for issuing tokenized assets with ownership controls, and CypherOS for privacy-focused trading and tokenization.
Those figures will not move Bitcoin’s hashrate. They do show why issuers keep filing for more crypto ETFs: professional capital wants clean custody, ticker access, and yield where staking exists.
How Could a Staked Altcoin ETF Help Bitcoin?
Bitcoin remains the benchmark institutional crypto allocation, and every successful crypto ETF launch reinforces that habit.
As we covered when Bitcoin ETF inflows raised hopes of fresh buying, traditional accounts already treat spot Bitcoin funds as the core on-ramp.
A staked INJ product does not compete with that role. It sits further out on the risk curve, the way satellite holdings sit beside a Bitcoin core position.
We would look for the same pattern that followed the first spot Bitcoin ETFs: brokers get comfortable, compliance desks write policies, and the next product becomes easier to approve and distribute.
That plumbing favors Bitcoin first. Liquidity, brand recognition, and the longest ETF track record still belong to BTC.
Recent flow snapshots, including days when Bitcoin ETF inflows hit about $75 million, show how quickly capital can rotate back into the flagship when risk appetite returns.
What Are Markets Saying While This ETF Debuts?
The launch landed in a choppy tape. Bitcoin was recently down about 5% on the day while holding above $76,000, as crypto tracked a tech-led sell-off.
INJ’s relative strength on the announcement day is a classic ETF-catalyst pattern: the newly packaged asset catches a bid while the broader complex digests leverage flushes.
Cycle analyst Bob Loukas has been constructive on Bitcoin’s longer rhythm even as shorter cycles grind lower.
“Lot of questions on Bitcoin’s 4yr Cycle. I’m of the view the cycle low is well in. But the weekly Cycle is in decline. Any drop over the next few months is part of that process and back-filling,” Loukas wrote.
We share the constructive read. Soft sessions after midterms and equity stress can look ugly on a daily chart, yet they often refill inventory for the next institutional bid.
As we noted when Bitcoin dipped below $76,000, resets have repeatedly been absorbed when ETF and treasury demand stay in the picture.
Could More Staked Crypto ETFs Follow Bitcoin’s Lead?
Canary Capital already lists XRP and HBAR products alongside the new INJ fund. That lineup signals issuers expect demand for more than one liquid crypto ETF sleeve.
For us, the key takeaway is sequencing. Bitcoin opened the door. Ether funds normalized staking conversations inside regulated wrappers. Altcoin and staked products test how far the same distribution channel can go.
Watch the practical checklist that always matters for BTC: Nasdaq and broader equity tone, Treasury yields, the dollar, spot Bitcoin ETF flows, and whether volume confirms any bounce above recent lows.
A firm close back through the mid-$70,000s toward $80,000 would need a few percentage points of recovery and, more importantly, sustained ETF demand.
We believe Bitcoin’s fixed supply and deepening brokerage access still set the standard every other crypto ETF is measured against.
The coming weeks will show whether staked products like Canary Capital’s INJ fund pull new tickets into digital assets. And if they do, Bitcoin is positioned to remain the core holding those same accounts scale first.
DC Forecasts is a leader in many crypto news categories, striving for the highest journalistic standards and abiding by a strict set of editorial policies. If you are interested to offer your expertise or contribute to our news website, feel free to contact us at [email protected]
Discussion about this post